TGF[beta] inhibition enhances the generation of hematopoietic progenitors from human ES cell-derived hemogenic endothelial cells using a stepwise strategy

• Published in: Cell research Vol. 22; no. 1; p. 194
• Main Authors: Wang, Chengyan, Tang, Xuming, Sun, Xiaomeng, Miao, Zhenchuan, Lv, Yaxin, Yang, Yanlei, Zhang, Huidan, Zhang, Pengbo, Liu, Yang, Du, Liying, Gao, Yang, Yin, Ming, Ding, Mingxiao, Deng, Hongkui
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group 01.01.2012
• ISSN: 1001-0602; 1748-7838
• DOI: 10.1038/cr.2011.138

Embryonic hematopoiesis is a complex process. Elucidating the mechanism regulating hematopoietic differentiation from pluripotent stem cells would allow us to establish a strategy to efficiently generate hematopoietic cells. However, the mechanism governing the generation of hematopoietic progenitors from human embryonic stem cells (hESCs) remains unknown. Here, on the basis of the emergence of CD43(+) hematopoietic cells from hemogenic endothelial (HE) cells, we demonstrated that VEGF was essential and sufficient, and that bFGF was synergistic with VEGF to specify the HE cells and the subsequent transition into CD43(+) hematopoietic cells. Significantly, we identified TGF[beta] as a novel signal to regulate hematopoietic development, as the TGF[beta] inhibitor SB 431542 significantly promoted the transition from HE cells into CD43(+) hematopoietic progenitor cells (HPCs) during hESC differentiation. By defining these critical signaling factors during hematopoietic differentiation, we can efficiently generate HPCs from hESCs. Our strategy could offer an in vitro model to study early human hematopoietic development.